Jiangsu Nhwa Pharmaceutical Co Ltd
002262 · SHE · Healthcare / Drug Manufacturers - Specialty & Generic
Price History
Full chartMarket Stats
About
Jiangsu Nhwa Pharmaceutical Co., LTD engages in research, development, production, and sale of central nervous system products in China. The company offers APIs, solid preparation, water injection, and freeze-dried powder formulations for depression, anxiety disorders, insomnia, severe mental disorders, and neurodegenerative diseases. Its products include sufentanil citrate injection, oxaliplatin fumarate injection, alfentanil hydrochloride injection, oxycodone hydrochloride injection, olanzapine tablets, midazolam hydrochloride oral solution, clonazepam injection, lacosamide injection, micuronium injection, pregabalin capsules, vortioxetine hydrobromide tablets, tapentadone hydrochloride tablets, and oxycodone hydrochloride extended-release tablets. The company was founded in 1978 and is headquartered in Xuzhou, China.
Company Details
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
- CEOMr. Jiaquan Sun
- Employees6.00K
- HeadquartersEnhua Technology Building, Xuzhou, China, 221009, China
- Websitehttps://www.nhwa-group.com
Leadership
- Mr. Jiaquan SunGM & Non-Independent Director · b. 1976
- Mr. Gangsheng LiChief Financial Officer · b. 1980
- Mr. Qing FuDeputy GM & Non-Independent Director · b. 1961
- Mr. Zengliang ChenDeputy GM & Non-Independent Director · b. 1963
- Mr. Ziliang YangDeputy GM & Non-Independent Director · b. 1964
- Mr. Bao Zhou Duan CPADeputy GM & Secretary · b. 1966
- Ji Rui HuAccounting Supervisor
Financials
Income Statement
Balance Sheet
Cash Flow
Earnings
Key Statistics & Ratios
Dividends
Stock Splits
- May 12, 201716:10
- Jun 8, 201613:10
- Apr 8, 201512:10
- May 28, 201412:10
- Jun 5, 20131.25:1
- Jun 1, 20101.3:1
- Jun 10, 200915:10